Virtus LifeSci Biotech Clinical Trials ETF
18 hedge funds and large institutions have $39.5M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
18
Holders Change
+6
Holders Change %
+50%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
6
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Jane Street
New York
|
$336K |
2 |
CA
2
Calton & Associates
Tampa,
Florida
|
$0 |
3 |
3
Goldman Sachs
New York
|
$3.28M |
4 |
ASN
4
Advisory Services Network
Atlanta,
Georgia
|
$3.54M |